Cargando…

Consequences of oral antithrombotic use in patients with chronic kidney disease

We assessed the risks of bleeding, acute kidney injury (AKI), and kidney failure associated with the prescription of antithrombotic agents (oral anticoagulants and/or antiplatelet agents) in patients with moderate‐to‐advanced chronic kidney disease (CKD). CKD‐REIN is a prospective cohort of 3022 nep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laville, Solène M., Lambert, Oriane, Hamroun, Aghiles, Metzger, Marie, Jacquelinet, Christian, Laville, Maurice, Frimat, Luc, Fouque, Denis, Combe, Christian, Ayav, Carole, Pecoits‐Filho, Roberto, Stengel, Bénédicte, Massy, Ziad A., Liabeuf, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604253/ https://www.ncbi.nlm.nih.gov/pubmed/34080321 http://dx.doi.org/10.1111/cts.13084

Ejemplares similares

Urea levels and cardiovascular disease in patients with chronic kidney disease
por: Laville, Solène M, et al.
Publicado: (2022)

Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease
por: Prezelin-Reydit, Mathilde, et al.
Publicado: (2023)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

Impact of age on cardiovascular drug use in patients with chronic kidney disease
por: Villain, Cédric, et al.
Publicado: (2019)

Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study
por: Stengel, Bénédicte, et al.
Publicado: (2014)

Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study
por: Alencar de Pinho, Natalia, et al.
Publicado: (2017)

Predictors of nonfunctional arteriovenous access at hemodialysis initiation and timing of access creation: A registry-based study
por: Alencar de Pinho, Natalia, et al.
Publicado: (2017)

Prescription of Direct Oral Anticoagulants to Patients With Moderate-to-Advanced CKD: Too Little or Just Right?
por: Liabeuf, Sophie, et al.
Publicado: (2021)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Prediction of chronic kidney disease after acute kidney injury in ICU patients: study protocol for the PREDICT multicenter prospective observational study
por: Geri, Guillaume, et al.
Publicado: (2018)

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2020)

Patient perspectives on chronic kidney disease and decision-making about treatment. Discourse of participants in the French CKD-REIN cohort study
por: Montalescot, Lucile, et al.
Publicado: (2022)

Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review
por: Pluquet, Maxime, et al.
Publicado: (2022)

Practice patterns of dialysis access and outcomes in patients wait-listed early for kidney transplantation
por: Sylvestre, Raphaëlle, et al.
Publicado: (2020)

Effects of the dialysate calcium concentrations and mineral bone disease treatments on mortality in The French Renal Epidemiology and Information Network (REIN) registry
por: Lambert, Oriane, et al.
Publicado: (2020)

Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia
por: Guedes, Murilo, et al.
Publicado: (2021)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
por: Rey, Amayelle, et al.
Publicado: (2019)

Should We Use Standard Survival Models or the Illness-Death Model for Interval-Censored Data to Investigate Risk Factors of Chronic Kidney Disease Progression?
por: Boucquemont, Julie, et al.
Publicado: (2014)

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation
por: Marienne, Justine, et al.
Publicado: (2020)

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care
por: Pecoits‐Filho, Roberto, et al.
Publicado: (2019)

Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients
por: Hamroun, Aghilès, et al.
Publicado: (2019)

From old uraemic toxins to new uraemic toxins: place of ‘omics’
por: Massy, Ziad A, et al.
Publicado: (2018)

Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly
por: Kaboré, Jean, et al.
Publicado: (2016)

What does the French REIN registry tell us about Stage 4-5 CKD care in older adults?
por: Moranne, Olivier, et al.
Publicado: (2023)

Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?
por: Cheddani, Lynda, et al.
Publicado: (2021)

Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase(®))
por: Dernoncourt, Amandine, et al.
Publicado: (2022)

Lack of Monitoring Is Associated with Risk of Acute Kidney Events among Patients with Inflammatory Bowel Disease
por: Achit, Hamza, et al.
Publicado: (2022)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
por: El Chamieh, Carolla, et al.
Publicado: (2022)

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy(†)
por: Fliser, Danilo, et al.
Publicado: (2012)

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease
por: Kaboré, Jean, et al.
Publicado: (2016)

The Authors Reply
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries
por: Stengel, Bénédicte, et al.
Publicado: (2020)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Impact of air pollution on renal outcomes: a systematic review and meta-analysis protocol
por: Hamroun, Aghilès, et al.
Publicado: (2021)

Global prevalence of spondyloarthritis in low-income and middle-income countries: a systematic review and meta-analysis protocol
por: Allado, Edem, et al.
Publicado: (2020)

Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study
por: Ayav, Carole, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1p0n8ekjq8bm6o5oslihq08njo